Literature DB >> 18660464

Role of dopamine in the motivational and cognitive control of behavior.

Roshan Cools1.   

Abstract

Brain dopamine has often been implicated in impulsive and/or inflexible behaviors, which may reflect failures of motivational and/or cognitive control. However, the precise role of dopamine in such failures of behavioral control is not well understood, not least because they implicate paradoxical changes in distinct dopamine systems that innervate dissociable neural circuits. In addition, there are large individual differences in the response to dopaminergic drugs with some individuals benefiting from and others being impaired by the same drug. This complicates progress in the understanding of dopamine's role in behavioral control processes, but also provides a major problem for neuropsychiatry, where some individuals are disproportionately vulnerable to the adverse effects of dopamine-enhancing drugs on motivation and cognition. Recent progress is reviewed from cognitive and behavioral neuroscience research on motivation and cognitive control, which begins to elucidate the factors that mediate the complex roles of mesolimbic, mesocortical, and nigrostriatal dopamine in behavioral control.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18660464     DOI: 10.1177/1073858408317009

Source DB:  PubMed          Journal:  Neuroscientist        ISSN: 1073-8584            Impact factor:   7.519


  118 in total

1.  Motivated cognitive control: reward incentives modulate preparatory neural activity during task-switching.

Authors:  Adam C Savine; Todd S Braver
Journal:  J Neurosci       Date:  2010-08-04       Impact factor: 6.167

2.  Reward, attention, and HIV-related risk in HIV+ individuals.

Authors:  Brian A Anderson; Sharif I Kronemer; Jessica J Rilee; Ned Sacktor; Cherie L Marvel
Journal:  Neurobiol Dis       Date:  2015-10-17       Impact factor: 5.996

3.  The effects of methylphenidate on cerebral responses to conflict anticipation and unsigned prediction error in a stop-signal task.

Authors:  Peter Manza; Sien Hu; Jaime S Ide; Olivia M Farr; Sheng Zhang; Hoi-Chung Leung; Chiang-shan R Li
Journal:  J Psychopharmacol       Date:  2016-01-11       Impact factor: 4.153

4.  Sleep deprivation is associated with attenuated parametric valuation and control signals in the midbrain during value-based decision making.

Authors:  Mareike M Menz; Christian Büchel; Jan Peters
Journal:  J Neurosci       Date:  2012-05-16       Impact factor: 6.167

Review 5.  Dysfunctions of decision-making and cognitive control as transdiagnostic mechanisms of mental disorders: advances, gaps, and needs in current research.

Authors:  Thomas Goschke
Journal:  Int J Methods Psychiatr Res       Date:  2014-01       Impact factor: 4.035

6.  The metabotropic glutamate 2/3 receptor agonist LY379268 counteracted ketamine-and apomorphine-induced performance deficits in the object recognition task, but not object location task, in rats.

Authors:  Nikolaos Pitsikas; Athina Markou
Journal:  Neuropharmacology       Date:  2014-05-20       Impact factor: 5.250

7.  Working memory ability predicts trajectories of early alcohol use in adolescents: the mediational role of impulsivity.

Authors:  Atika Khurana; Dan Romer; Laura M Betancourt; Nancy L Brodsky; Joan M Giannetta; Hallam Hurt
Journal:  Addiction       Date:  2012-11-01       Impact factor: 6.526

8.  Learning the opportunity cost of time in a patch-foraging task.

Authors:  Sara M Constantino; Nathaniel D Daw
Journal:  Cogn Affect Behav Neurosci       Date:  2015-12       Impact factor: 3.282

9.  Conditioned task-set competition: Neural mechanisms of emotional interference in depression.

Authors:  Aleks Stolicyn; J Douglas Steele; Peggy Seriès
Journal:  Cogn Affect Behav Neurosci       Date:  2017-04       Impact factor: 3.282

10.  Effect of apomorphine on cognitive performance and sensorimotor gating in humans.

Authors:  Arnt F A Schellekens; K P Grootens; C Neef; Kris L L Movig; J K Buitelaar; B Ellenbroek; R J Verkes
Journal:  Psychopharmacology (Berl)       Date:  2009-10-16       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.